EU, Britain in row over export of coronavirus vaccines
Michel demanded Britain provide more transparency over the production and exports of COVID-19 vaccines to other countries. "The EU is a major multinational pharmaceuticals hub with massive production capacity and wants to the companies that respect their commitments to continue exporting. The EU has never stopped exporting," the EU chief stressed.
- World
- Anadolu Agency
- Published Date: 03:08 | 11 March 2021
- Modified Date: 03:21 | 11 March 2021
President of the European Council Charles Michel has asked the UK to disclose data on how many coronavirus vaccines it has exported after British Prime Minister Boris Johnson rejected the claims of "vaccine nationalism."
In an interview with Politico on Wednesday, Michel said the EU exports too many doses while accusing the UK of imposing an "outright ban" on the export of vaccines produced in the country.
"I know because I am a politician, that there are different ways to impose a ban or to impose restrictions on vaccines and/or on medicines, because on medicines there is a clear ban. But the question is the following: how many doses did they export? This is a very simple question, and since yesterday I haven't heard the answer to this very simple question," he said.
In a written statement Tuesday, Michel denied the accusations of "vaccine nationalism" against the EU, adding: "The United Kingdom and the United States have imposed an outright ban on the export of vaccines or vaccine components produced on their territory."
Rejecting Michel's claim, Johnson told the House of Commons Wednesday that his country "has not blocked the export of a single COVID-19 vaccine or vaccine components," adding that he opposes "vaccine nationalism in all its forms."
The vaccine row between the EU and UK started when the British-Swedish pharmaceutical company AstraZeneca announced earlier that it would not send COVID-19 vaccine doses it had committed to the EU within the promised time.
AstraZeneca has said it would supply the EU with 40 million doses of vaccines in the first quarter and 90 million in the second, while the EU officials claimed these are less than half of the amounts in the contract that the 27-member-bloc signed with AstraZeneca.
The EU administration, although not directly, said AstraZeneca sent the vaccine or vaccine components produced in its facilities in EU member states to the UK and launched an export control system.
EU officials are criticized for the slow vaccination process across the member states. While approximately one-third of the population in the US and UK and half of the population in Israel are vaccinated, this rate is only around 6.5% in the EU.